Literature DB >> 16449682

Central nervous system toxicity induced by irinotecan.

Paul Hamberg, Richard C J M Donders, Daan ten Bokkel Huinink.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16449682     DOI: 10.1093/jnci/djj034

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  6 in total

Review 1.  Drug-induced cerebellar ataxia: a systematic review.

Authors:  J van Gaalen; F G Kerstens; R P P W M Maas; L Härmark; B P C van de Warrenburg
Journal:  CNS Drugs       Date:  2014-12       Impact factor: 5.749

2.  FOLFIRINOX-induced reversible dysarthria: A case report and review of previous cases.

Authors:  Ayumu Matsuoka; Osamu Maeda; Megumi Inada-Inoue; Eizaburo Ohno; Yoshiki Hirooka; Yukihiro Yokoyama; Tsutomu Fujii; Masato Nagino; Hidemi Goto; Yuichi Ando
Journal:  Oncol Lett       Date:  2015-08-11       Impact factor: 2.967

3.  Pharmacokinetic evaluation of the anticancer prodrug simmitecan in different experimental animals.

Authors:  Zhe-yi Hu; Xiu-xue Li; Fei-fei Du; Jun-ling Yang; Wei Niu; Fang Xu; Feng-qing Wang; Chuan Li; Yan Sun
Journal:  Acta Pharmacol Sin       Date:  2013-09-23       Impact factor: 6.150

Review 4.  Role of inflammation and oxidative stress in chemotherapy-induced neurotoxicity.

Authors:  Pooja Gupta; Tavneet Kaur Makkar; Lavisha Goel; Monika Pahuja
Journal:  Immunol Res       Date:  2022-07-20       Impact factor: 4.505

5.  Pharmacokinetic and safety study of weekly irinotecan and oral capecitabine in patients with advanced solid cancers.

Authors:  Sanjay Goel; Kavita Desai; Sirisha Karri; Radharani Gollamudi; Imran Chaudhary; Anca Bulgaru; Andreas Kaubisch; Gary Goldberg; Mark Einstein; Fernando Camacho; Sharyn Baker; Sridhar Mani
Journal:  Invest New Drugs       Date:  2006-12-30       Impact factor: 3.651

6.  Irinotecan-induced dysarthria.

Authors:  Albertine J Dressel; Johannes C van der Mijn; Ijke J Aalders; Rico N P M Rinkel; Hans J van der Vliet
Journal:  Case Rep Oncol       Date:  2012-01-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.